Formal catalytic asymmetric total synthesis of fostriecin.

The common synthetic intermediate of a potent and promising anticancer agent, fostriecin, was synthesized using a unique method that combines four catalytic asymmetric reactions as shown above.

[1]  Yoichi M. A. Yamada,et al.  Direct Catalytic Asymmetric Aldol Reaction , 1999 .

[2]  Y. Hamashima,et al.  Catalytic Enantioselective Cyanosilylation of Ketones , 2000 .

[3]  T. Ikariya,et al.  Asymmetric Transfer Hydrogenation of a,-Acetylenic Ketones , 1997 .

[4]  A. Mapp,et al.  Total Synthesis of Myxalamide A. , 1999, The Journal of organic chemistry.

[5]  M. Kanai,et al.  Catalytic enantioselective cyanosilylation of ketones: improvement of enantioselectivity and catalyst turn-over by ligand tuning , 2001 .

[6]  M. Kanai,et al.  Switching enantiofacial selectivities using one chiral source: catalytic enantioselective synthesis of the key intermediate for (20S)-camptothecin family by (S)-selective cyanosilylation of ketones. , 2001, Journal of the American Chemical Society.

[7]  S. Shibuya,et al.  One Pot Synthesis of Haloacetylenes from Trimethylsilylacetylenes , 1994 .

[8]  B. Alcaide,et al.  The Direct Catalytic Asymmetric Aldol Reaction , 2002 .

[9]  M. Shibasaki,et al.  Asymmetric Catalysis with Heterobimetallic Compounds , 1997 .

[10]  Yuichi Kobayashi,et al.  Formal total synthesis of fostriecin. , 2002, Organic letters.

[11]  A. Yanagisawa,et al.  Enantioselective Addition of Allylic Trimethoxysilanes to Aldehydes Catalyzed byp-Tol-BINAP⋅AgF , 1999 .

[12]  M. Grier,et al.  Catalytic asymmetric allylation reactions. 3. Extension to methallylstannane, comparison of procedures, and observation of a nonlinear effect , 1993 .

[13]  J. Stille,et al.  Stereospecific cross-coupling of vinyl halides with vinyl tin reagents catalyzed by palladium , 1987 .

[14]  K. Miyashita,et al.  Total synthesis of fostriecin (CI-920) via a convergent route. , 2002, Chemical communications.

[15]  D. Boger,et al.  Fostriecin: chemistry and biology. , 2002, Current medicinal chemistry.

[16]  Yoichi M. A. Yamada,et al.  Direct Catalytic Asymmetric Aldol Reactions of Aldehydes with Unmodified Ketones , 1997 .

[17]  S. Stampwala,et al.  Novel antitumor agents CI-920, PD 113,270 and PD 113,271. II. Isolation and characterization. , 1983, The Journal of antibiotics.

[18]  J. Cossy,et al.  Synthesis of the C1-C12 fragment of fostriecin. , 2001, Organic letters.

[19]  M. Kanai,et al.  Recent progress in asymmetric two-center catalysis. , 2002, Chemical communications.

[20]  A. Myers,et al.  Preparation of the Reagent o-Nitrobenzenesulfonylhydrazide. , 1997, The Journal of organic chemistry.

[21]  W. E. Dobson,et al.  Novel antitumor agents CI-920, PD 113,270 and PD 113,271. I. Taxonomy, fermentation and biological properties. , 1983, The Journal of antibiotics.

[22]  E. Jacobsen,et al.  Total Synthesis of Fostriecin (CI‐920) , 2001 .

[23]  D. Boger,et al.  Determination of the Relative and Absolute Stereochemistry of Fostriecin (CI-920) , 1997 .

[24]  Robert H. Grubbs,et al.  Recent advances in olefin metathesis and its application in organic synthesis , 1998 .

[25]  J. Falck,et al.  Asymmetric total synthesis of (+)-fostriecin. , 2002, Organic letters.

[26]  T. Esumi,et al.  Versatile enantiocontrolled synthesis of (+)-fostriecin. , 2002, Chemical communications.